ES2083319A1 - 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)- 6 chloro-1,3-dihydro-2H-indole-2-one hydrochloride monohydrate - Google Patents

5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)- 6 chloro-1,3-dihydro-2H-indole-2-one hydrochloride monohydrate

Info

Publication number
ES2083319A1
ES2083319A1 ES09301981A ES9301981A ES2083319A1 ES 2083319 A1 ES2083319 A1 ES 2083319A1 ES 09301981 A ES09301981 A ES 09301981A ES 9301981 A ES9301981 A ES 9301981A ES 2083319 A1 ES2083319 A1 ES 2083319A1
Authority
ES
Spain
Prior art keywords
benzisothiazol
indole
dihydro
chloro
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09301981A
Other languages
Spanish (es)
Other versions
ES2083319B1 (en
Inventor
Douglas J M Allen
Frank R Busch
Sabeto A Diroma
Dennis M Godek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Priority to ES9301981A priority Critical patent/ES2083319B1/en
Publication of ES2083319A1 publication Critical patent/ES2083319A1/en
Application granted granted Critical
Publication of ES2083319B1 publication Critical patent/ES2083319B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

5-(2-(4-(1,2-benzisothiazol-3-yl)-1- piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-indole-2-one hydrochloride monohydrate. 5-(2-(4-(1,2-benzisothiazol-3-yl)- 1piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indole-2-one hydrochloride monohydrate has the advantage of stability for formulation as a neuroleptic agent.
ES9301981A 1993-09-20 1993-09-20 5- (2- (4- (1,2-BENZISOTIAZOL-3-IL) -1-PIPERAZINYL) -Ethyl) -6-CHLORINE-1,3-DIHYDRO-2H-INDOL-2-ONA MONOHYDRATE. Expired - Fee Related ES2083319B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9301981A ES2083319B1 (en) 1993-09-20 1993-09-20 5- (2- (4- (1,2-BENZISOTIAZOL-3-IL) -1-PIPERAZINYL) -Ethyl) -6-CHLORINE-1,3-DIHYDRO-2H-INDOL-2-ONA MONOHYDRATE.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9301981A ES2083319B1 (en) 1993-09-20 1993-09-20 5- (2- (4- (1,2-BENZISOTIAZOL-3-IL) -1-PIPERAZINYL) -Ethyl) -6-CHLORINE-1,3-DIHYDRO-2H-INDOL-2-ONA MONOHYDRATE.

Publications (2)

Publication Number Publication Date
ES2083319A1 true ES2083319A1 (en) 1996-04-01
ES2083319B1 ES2083319B1 (en) 1997-01-16

Family

ID=8283083

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9301981A Expired - Fee Related ES2083319B1 (en) 1993-09-20 1993-09-20 5- (2- (4- (1,2-BENZISOTIAZOL-3-IL) -1-PIPERAZINYL) -Ethyl) -6-CHLORINE-1,3-DIHYDRO-2H-INDOL-2-ONA MONOHYDRATE.

Country Status (1)

Country Link
ES (1) ES2083319B1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0281309A1 (en) * 1987-03-02 1988-09-07 Pfizer Inc. Piperazinyl-heterocyclic compounds
US4831031A (en) * 1988-01-22 1989-05-16 Pfizer Inc. Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
US4883795A (en) * 1988-01-22 1989-11-28 Pfizer Inc. Piperazinyl-heterocyclic compounds
EP0586191A1 (en) * 1992-09-01 1994-03-09 Pfizer Inc. Monohydrate of 5-(2-(4-(1,2 Benzisothiazol-3-YL)-1-Piperazinyl)-Ethyl)-6-Chloro-1,3-Dihydro-2H-indol-2-one Hydrochloride

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0281309A1 (en) * 1987-03-02 1988-09-07 Pfizer Inc. Piperazinyl-heterocyclic compounds
US4831031A (en) * 1988-01-22 1989-05-16 Pfizer Inc. Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
US4883795A (en) * 1988-01-22 1989-11-28 Pfizer Inc. Piperazinyl-heterocyclic compounds
EP0586191A1 (en) * 1992-09-01 1994-03-09 Pfizer Inc. Monohydrate of 5-(2-(4-(1,2 Benzisothiazol-3-YL)-1-Piperazinyl)-Ethyl)-6-Chloro-1,3-Dihydro-2H-indol-2-one Hydrochloride

Also Published As

Publication number Publication date
ES2083319B1 (en) 1997-01-16

Similar Documents

Publication Publication Date Title
CA2105114A1 (en) Monohydrate of 5-(2-(4-(1,2 Benzisothiazol-3-Yl)-1- Piperazinyl)-Ethyl)-6-Chloro-1,3-Dihydro-2H-Indol-2-One Hydrochloride
RU93043528A (en) 5- (2- (4- (1,2-BENZOTIAZOL-3-IL) -1-PIPERAZINYL) Ethyl MONOHYDRATE) -6-CHLOR-1,3-DIHYDRO-2H-INDOL-2-OH CHLOROHYDRATE, METHOD FOR ITS PREPARATION , PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT
AP2001002066A0 (en) Substituted oxazoles and thiazoles derivatives at hPPAR gamma and hPPAR alpha activators
AU666413B2 (en) Antiallergic composition for opthalmic or nasal use
TR200000812T2 (en) 2-methyl-thieno-benzodiazepine formulation.
WO2001032652A3 (en) N-substituted carbamoyloxyalkyl-azolium derivatives
WO1999009025A3 (en) 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives interacting with the dopamine d4 receptor
GB9718903D0 (en) Method,compositions and kits for increasing the oral bioavailability of pharmaceutical agents
EP0816362A4 (en) Thiazole derivatives
MX9701116A (en) Pro-drugs of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chl oro-1,3-dihydro-2h-indol-2-one.
ES2083319A1 (en) 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)- 6 chloro-1,3-dihydro-2H-indole-2-one hydrochloride monohydrate
CA2244621A1 (en) 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide y receptor antagonists
HU9202914D0 (en) 4-(4-(4-hydroxiphenyl)-1-piperazinyl)-5-methyl-3h-1,2,4-triazole-3-one derivatives
PL348601A1 (en) New pharmaceutical composition and the process for its preparation
MY109504A (en) Monohydrate of 5-(2-(4-(1,2 benzisothiazol-3-yl)-1- piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2h-indol-2- one hydrochloride
CA2423357A1 (en) Fused heterocyclic derivatives as phosphodiesterase inhibitors
ES8504185A1 (en) Spirothiazolidinyl piperazine derivatives
AU779761C (en) Medicament for treatment of neuropathies
GB0021784D0 (en) Novel pharmaceutical
AP1738A (en) Sodium salts of 5-[4-[2-(N-Methyl -N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione.
ES2062940A1 (en) Gastrokinetic agent, process for its preparation and pharmaceutical compositions containing said agent
EP0878475A3 (en) 5-(4-Piperidinyl)dibenzothiazepine derivatives and 5-(4-piperidinyl)dibenzoxazepine derivatives, and antiarrhythmic agents
MY110446A (en) Piperazine derivatives
AU1272701A (en) Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4- dimethoxyphenyl)ethoxy)-3,3-diphenylpropionate and use thereof as endothelin antagonist
HUP9902404A3 (en) Mesylate dihydrate salts of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-choloro-1,3-dihydro-2(2h)-indol-2-one (-ziprasidone), its preparation and its use as dopamine d2 antagonist

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19930920

Kind code of ref document: B1

Effective date: 19930920

FD2A Announcement of lapse in spain

Effective date: 20141120